IDH1 and cancer: For instance, the most recurrently observed nullomer was found at BRAF across 5.5% of cancer patients, while other top emerging nullomers were found at individual loci in IDH1, PIK3CA, KRAS and TP53 (Table 1), all of which are known cancer genes.